Article
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices.
Journal of viral hepatitis - 1 Feb 2013
Di Marco V, Calvaruso V, Grimaudo S, Ferraro D, Pipitone R M, Di Stefano R, Craxì A
Abstract excerpt
Genetic factors can influence the outcome of antiviral therapy in chronic hepatitis C (HCV). We evaluated the role of interleukin-28B single nucleotide polymorphisms (SNPs) and inosine triphosphatase (ITPA) gene variants in HCV cirrhosis treated with Peg-Interferon and ribavirin. A prospective cohort of 233 patients with compensated cirrhosis received 1-1.5 μg/kg/week of Peg-Interferon alpha-2b plus 1000-1200...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.